Burch colposuspension decreases postop SUI
Adding Burch colposuspension to abdominal sacrocolpopexy for the treatment of pelvic-organ prolapse approximately halves the incidence of postoperative stress urinary incontinence (SUI) in women who do not have SUI preoperatively and does so without increasing other lower urinary tract symptoms, according to the results of a randomized controlled trial.
Adding Burch colposuspension to abdominal sacrocolpopexy for the treatment of pelvic-organ prolapse approximately halves the incidence of postoperative stress urinary incontinence (SUI) in women who do not have SUI preoperatively and does so without increasing other lower urinary tract symptoms, according to the results of a randomized controlled trial.
Researchers included 322 women in the study. Three months after surgery, 23.8% of the women receiving the Burch procedure and 44.1% of the women in the control group had SUI (P<0.001). Additionally, those in the control group were four times more likely than those in the Burch group to report bothersome symptoms surrounding the condition (24.5% vs. 6.1%; P<0.001). Neither group was more likely to develop urge incontinence.
Brubaker L, Cundiff GW, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354:1557-1566.
Tebipenem HBr cUTI trial ends early after meeting efficacy goals
May 28th 2025GSK and Spero Therapeutics announced that the phase 3 PIVOT-PO trial for tebipenem HBr, a potential first oral carbapenem for cUTIs in the United States, was stopped early because of positive efficacy results.
Read More
